Role of vitamin C as an adjuvant therapy to different iron chelators in young β-thalassemia major patients: efficacy and safety in relation to tissue iron overload-Reference-Cited by-同舟云学术

Role of vitamin C as an adjuvant therapy to different iron chelators in young β-thalassemia major patients: efficacy and safety in relation to tissue iron overload

Published:2015-06-25 Issue:3 Volume:96 Page:318-326
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Elalfy Mohsen S.¹,Saber Maha M.²,Adly Amira Abdel Moneam¹,Ismail Eman A.³,Tarif Mohamed³,Ibrahim Fatma²,Elalfy Omar M.²

Affiliation:

1. Pediatrics Department; Faculty of Medicine; Ain Shams University; Cairo Egypt

2. Child Health in Complementary Medicine; National Research Center; Cairo Egypt

3. Clinical Pathology Department; Faculty of Medicine; Ain Shams University; Cairo Egypt

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejh.12594/fullpdf

Reference58 articles.

1. Brazilian Thalassemia Association protocol for iron chelation therapy in patients under regular transfusion;Veríssimo;Rev Bras Hematol Hemoter,2013

2. Italian society of hematology practice guidelines for the management of iron overload in thalassemia major and related disorders;Angelucci;Haematologica,2008

3. The management of iron chelation therapy: preliminary data from a national registry of thalassaemic patients;Ceci;Anemia,2011

4. Objectives and mechanism of iron chelation therapy;Hershko;Ann N Y Acad Sci,2005

5. Safety and efficacy of iron chelation therapy with deferiprone in patients with transfusion-dependent thalassemia;Jamuar;Ther Adv Hematol,2012

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and Pharmacokinetics of a Combined Antioxidant Therapy against Myocardial Reperfusion Injury: A Phase 1 Randomized Clinical Trial in Healthy Humans;Clinical Pharmacology in Drug Development;2024-07-08

2. The Importance and Essentiality of Natural and Synthetic Chelators in Medicine: Increased Prospects for the Effective Treatment of Iron Overload and Iron Deficiency;International Journal of Molecular Sciences;2024-04-25

3. Drug Selection and Posology, Optimal Therapies and Risk/Benefit Assessment in Medicine: The Paradigm of Iron-Chelating Drugs;International Journal of Molecular Sciences;2023-11-25

4. Iron and Targeted Iron Therapy in Alzheimer’s Disease;International Journal of Molecular Sciences;2023-11-15

5. Iron chelators as a therapeutic option for Alzheimer’s disease—A mini-review;Frontiers in Aging;2023-08-02